Company: THC
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001193125-25-079143
Chunk: 12

Company: TENET HEALTHCARE CORP
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 12
---
 his B.A. in economics from Harvard University and earned his M.B.A. from Stanford University. |

Skills and Qualifications:

| • |     | Mr. Fisher offers valuable financial and policy perspectives from his experience as President and Chief Executive Officer of the Dallas Federal Reserve and from his service on the board of directors of public companies that include AT&T Inc., PepsiCo, Inc. and Warner Bros. Discovery, Inc. |

| • |     | The Board values his insight in public finance, trade, technology and risk management. |

Other Current Public Company Directorships:

| • |     | Warner Bros. Discovery, Inc. |

Prior Public Company Directorships Within the Past Five Years:

| • |     | AT&T Inc. |

| • |     | Beneficient |

| • |     | PepsiCo, Inc. |

| 2025 PROXY STATEMENT |     | 13 |

Director Nominees

| Meghan M. FitzGerald, DrPH                                                                    |     |                          |
| Adjunct Professor Columbia University                                                         |     | Director Since 2018      |
| Board Committees ESG Nominating and Corporate Governance (Chair) Quality, Compliance & Ethics |     | Independent Yes   Age 54 |

Career Highlights:

| • |     | Ms. FitzGerald is a private equity investor, and she serves as an advisor to several firms, including Goldman Sachs, TowerBrook and Wellspring Capital, a private equity firm focused on leveraged buyout investments. |

| • |     | In addition, she serves as an Adjunct Professor of Health Policy at Columbia University, a private university. |

| • |     | Ms. FitzGerald served from December 2016 to January 2020 as the CEO and managing partner at Letter One’s inaugural health vehicle. |

| • |     | Prior to that, she served for nearly 20 years as an operator and strategist working for many healthcare firms, including Merck, Pfizer and Medco. |

| • |     | From May 2015 to October 2016, Ms. FitzGerald served as Executive Vice President of Strategy and Policy at Cardinal Health, a healthcare services and product company. From 2010 to 2015, she served as President of Cardinal’s Specialty Solutions division. |

| • |     | Ms. FitzGerald also previously served as a director of Thimble Point Acquisition Corp. from February to December 2021 and Arix Bioscience plc from 2017 to 2019.